Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1980 Jul 1;189(1):9–15. doi: 10.1042/bj1890009

The interrelations between high- and low-molecular-weight forms of normal and mutant (Krabbe-disease) galactocerebrosidase

Yoav Ben-Yoseph 1, Melinda Hungerford 1, Henry L Nadler 1
PMCID: PMC1161912  PMID: 7458907

Abstract

Galactocerebrosidase (β-d-galactosyl-N-acylsphingosine galactohydrolase; EC 3.2.1.46) activity of brain and liver preparations from normal individuals and patients with Krabbe disease (globoid-cell leukodystrophy) have been separated by gel filtration into four different molecular-weight forms. The apparent mol.wts. were 760000±34000 and 121000±10000 for the high- and low-molecular-weight forms (peaks I and IV respectively) and 499000±22000 (mean±s.d.) and 256000±12000 for the intermediate forms (peaks II and III respectively). On examination by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, the high- and low-molecular-weight forms revealed a single protein band with a similar mobility corresponding to a mol.wt. of about 125000. Antigenic identity was demonstrated between the various molecular-weight forms of the normal and the mutant galactocerebrosidases by using antisera against either the high- or the low-molecular-weight enzymes. The high-molecular-weight form of galactocerebrosidase was found to possess higher specific activity toward natural substrates when compared with the low-molecular-weight form. It is suggested that the high-molecular-weight enzyme is the active form in vivo and an aggregation process that proceeds from a monomer (mol.wt. approx. 125000) to a dimer (mol.wt. approx. 250000) and from the dimer to either a tetramer (mol.wt. approx. 500000) or a hexamer (mol.wt. approx. 750000) takes place in normal as well as in Krabbe-disease tissues.

Full text

PDF
9

Images in this article

12Fig. 3.
on p.12

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axén R., Porath J., Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature. 1967 Jun 24;214(5095):1302–1304. doi: 10.1038/2141302a0. [DOI] [PubMed] [Google Scholar]
  2. Ben-Yoseph Y., Burton B. K., Nadler H. L. Quantitation of the enzymically deficient cross reacting material in GM1 gangliosidoses. Am J Hum Genet. 1977 Nov;29(6):575–580. [PMC free article] [PubMed] [Google Scholar]
  3. Ben-Yoseph Y., Defranco C. L., Nadler H. L. Decreased sialic acid and altered binding to lectins of purified alpha 2-macroglobulin from patients with cystic fibrosis. Clin Chim Acta. 1979 Nov 15;99(1):31–35. doi: 10.1016/0009-8981(79)90136-0. [DOI] [PubMed] [Google Scholar]
  4. Ben-Yoseph Y., Hungerford M., Nadler H. L. Galactosylceramide beta-galactosidase in Krabbe disease: partial purification and characterization of the mutant enzyme. Arch Biochem Biophys. 1979 Aug;196(1):93–101. doi: 10.1016/0003-9861(79)90555-1. [DOI] [PubMed] [Google Scholar]
  5. Ben-Yoseph Y., Hungerford M., Nadler H. L. The nature of mutation in Krabbe disease. Am J Hum Genet. 1978 Nov;30(6):644–652. [PMC free article] [PubMed] [Google Scholar]
  6. Ben-Yoseph Y., Shapira E., Edelman D., Burton B. K., Nadler H. L. Purification and properties of neutral beta-galactosidases from human liver. Arch Biochem Biophys. 1977 Dec;184(2):373–380. doi: 10.1016/0003-9861(77)90364-2. [DOI] [PubMed] [Google Scholar]
  7. Ben-Yoseph Y., Shapira E., Russell A. Quantitative determination of human carbonic anhydrase B isozyme. Isr J Med Sci. 1971 Sep;7(9):1050–1054. [PubMed] [Google Scholar]
  8. Besley G. T., Bain A. D. Krabbe's globoid cell leucodystrophy. Studies on galactosylceramide beta-galactosidase and non-specific beta-galactosidase of leucocytes, cultured skin fibroblasts, and amniotic fluid cells. J Med Genet. 1976 Jun;13(3):195–199. doi: 10.1136/jmg.13.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  10. Cheetham P. S., Dance N. E. The separation and characterization of the methylumbelliferyl beta-galactosidases of human liver. Biochem J. 1976 Jul 1;157(1):189–195. doi: 10.1042/bj1570189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gordon Julius A., Blumberg Shmaryahu, Lis Halina, Sharon Nathan. Purification of soybean agglutinin by affinity chromatography On sepharose-N-epsilon-aminocaproyl-beta-D-galactopyranosylamine. FEBS Lett. 1972 Aug 1;24(2):193–196. doi: 10.1016/0014-5793(72)80765-8. [DOI] [PubMed] [Google Scholar]
  12. Hajra A. K., Bowen D. M., Kishimoto Y., Radin N. S. Cerebroside galactosidase of brain. J Lipid Res. 1966 May;7(3):379–386. [PubMed] [Google Scholar]
  13. Ho M. W., Cheetham P., Robinson D. Hydrolysis of GM1-ganglioside by human liver beta-galactosidase isoenzymes. Biochem J. 1973 Oct;136(2):351–359. doi: 10.1042/bj1360351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ho M. W., O'Brien J. S. Stimulation of acid beta-galactosidase activity by chloride ions. Clin Chim Acta. 1970 Nov;30(2):531–534. doi: 10.1016/0009-8981(70)90147-6. [DOI] [PubMed] [Google Scholar]
  15. Holloway P. W. A simple procedure for removal of Triton X-100 from protein samples. Anal Biochem. 1973 May;53(1):304–308. doi: 10.1016/0003-2697(73)90436-3. [DOI] [PubMed] [Google Scholar]
  16. LEVY H. B., SOBER H. A. A simple chromatographic method for preparation of gamma globulin. Proc Soc Exp Biol Med. 1960 Jan;103:250–252. doi: 10.3181/00379727-103-25476. [DOI] [PubMed] [Google Scholar]
  17. Lo J., Mukerji K., Awasthi Y. C., Hanada E., Suzuki K., Srivastava S. K. Purification and properties of sphingolipid beta-galactosidases from human placenta. J Biol Chem. 1979 Jul 25;254(14):6710–6715. [PubMed] [Google Scholar]
  18. Miyatake T., Suzuki K. Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase. Biochem Biophys Res Commun. 1972 Aug 7;48(3):539–543. doi: 10.1016/0006-291x(72)90381-6. [DOI] [PubMed] [Google Scholar]
  19. Norden A. G., Tennant L. L., O'Brien J. S. GM1 ganglioside beta-galactosidase. A. Purification and studies of the enzyme from human liver. J Biol Chem. 1974 Dec 25;249(24):7969–7976. [PubMed] [Google Scholar]
  20. O'Brien J. E., Majewski J. C. Effects of de-icing salt on ground water characteristics. Environ Lett. 1975;8(4):303–313. doi: 10.1080/00139307509437440. [DOI] [PubMed] [Google Scholar]
  21. Radin N. S., Hof L., Bradley R. M., Brady R. O. Lactosylceramide galactosidase: comparison with other sphingolipid hydrolases in developing rat brain. Brain Res. 1969 Jul;14(2):497–505. doi: 10.1016/0006-8993(69)90124-3. [DOI] [PubMed] [Google Scholar]
  22. Suzuki K., Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci U S A. 1970 Jun;66(2):302–309. doi: 10.1073/pnas.66.2.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Suzuki Y., Suzuki K. Glycosphingolipid beta-galactosidases. I. Standard assay procedures and characterization by electrofocusing and gel filtration of the enzymes in normal human liver. J Biol Chem. 1974 Apr 10;249(7):2098–2104. [PubMed] [Google Scholar]
  24. Svennerholm L., Häkansson G., Vanier M. T. Chemical pathology of krabbe's disease. IV. Studies of galactosylceramide and lactosylceramide BETA-galactosidases in brain, white blood cells and aminotic fluid cells. Acta Paediatr Scand. 1975 Jul;64(4):649–656. doi: 10.1111/j.1651-2227.1975.tb03897.x. [DOI] [PubMed] [Google Scholar]
  25. Tanaka H., Suzuki K. Lactosylceramide beta-galactosidase in human sphingolipidoses. Evidence for two genetically distinct enzymes. J Biol Chem. 1975 Mar 25;250(6):2324–2332. [PubMed] [Google Scholar]
  26. Tanaka H., Suzuki K. Substrate specificities of the two genetically distinct human brain beta-galactosidases. Brain Res. 1977 Feb 18;122(2):325–335. doi: 10.1016/0006-8993(77)90298-0. [DOI] [PubMed] [Google Scholar]
  27. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  28. Wenger D. A., Satter M., Markey J. P. Deficiency of monogalactosyl diglycerid beta-B-galactosidase activity in krabbe's disease. Biochem Biophys Res Commun. 1973 Jul 17;53(2):680–685. doi: 10.1016/0006-291x(73)90715-8. [DOI] [PubMed] [Google Scholar]
  29. Wenger D. A., Sattler M., Hiatt W. Globoid cell leukodystrophy: deficiency of lactosyl ceramide beta-galactosidase. Proc Natl Acad Sci U S A. 1974 Mar;71(3):854–857. doi: 10.1073/pnas.71.3.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. da Wenger, Sattler M., Clark C. Effect of bile salts on lactosylceramide beta-galactosidase activities in human brain, liver and cultured skin fibroblasts. Biochim Biophys Acta. 1975 Dec 17;409(3):297–303. doi: 10.1016/0005-2760(75)90025-9. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES